


FDA Warns Invokana May Lead To Ketoacidosis
By: Marilyn McGoldrick, Esq. The Food and Drug Administration recently issued a Drug Safety Communication warning doctors and patients that taking the new class of diabetes drugs known as SGLT2 inhibitors — including Invokana — may lead to high levels of blood acids...